Novel Coronavirus Infectious Disease (COVID-19) COVID-19 pneumonia
Conditions
Interventions
None listed
Sponsors
Sawa Yoshiki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) 20 years old or older at informed consent 2) SARS-CoV-2 positive 3) COVID-19 Patients diagnosed with mild, moderate I or moderate II 4) Patients who have given written consent to participate
Exclusion criteria
Exclusion criteria: 1) Patients who are considered inappropriate for inclusion in the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity for changes to "moderate II / severe" | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Optimization of cutoff value for change to "moderate II / severe" 2) Comparison of RST values between the "mild / moderate I" group and the "moderate II / severe" group 3) Comparison of RST values by presence or absence of pneumonia findings 4) Change in RST value from admission to exacerbation | — |
Contacts
Public ContactShigeru Miyagawa
Osaka University Hospital
Outcome results
None listed